Clinical Microbiology Conference
5.5 CME Credits
5 - 8 February 2024
Dubai World Trade Centre
22 Jan - 22 Feb 2024
Clinical Microbiology Conference
5.5 CME Credits
Overview:
In the last two years, progress have been made toward COVID-19 therapies and vaccines. However, other infectious diseases have emerged and now pose's a new set of challenges for diagnostics laboratories. This conference will focus on testing and management of monkeypox, interesting case studies in clinical microbiology and infectious disease serology, and best practices for lab management. This track will offer a unique platform for clinical scientists, young researchers, and consultants in medical microbiology to exchange their knowledge and views on the current developments in this field.
Key topics:
- Educating the healthcare workforce in antimicrobial resistance and stewardship (AMS)
- New checklists in the CAP accreditation
- Essentials of a reliable microbiology report
- Case studies in clinical microbiology
- Interesting cases in infectious diseases serology
- How should labs be prepared for next unknown?
- Utility of whole genome sequencing
Benefits of attending:
- Discuss the usage of biochemical markers of sepsis
- Gain insights on infectious diseases serology cases
- Describe the epidemiology of monkeypox
- Define the best practices and strategies for labs for the next unknown
Chairs:
- Dr Adnan Alatoom, Clinical Microbiology Consultant, Sheikh Shakbout Medical City, Abu Dhabi, UAE
- Dr Wael Faroug Mohamed Elamin, Consultant Clinical Microbiologist, G42 Healthcare, Honorary Senior Clinical Lecturer, Queen Mary University London, Abu Dhabi, UAE
Activity Director:
- Dr Ziad Peerwani, Medical Director, Cleveland Clinic Laboratories, Pathology & Laboratory. Medicine Institute-PLMI, Cleveland Clinic, Cleveland, Ohio, USA
Speakers:
- Dr Ahmed Shibl, Research Associate, Genetic Heritage Group, New York University Abu Dhabi, Abu Dhabi, UAE
- Prof Angharad Davies, Vice-President for Learning, Royal College of Pathologists, London, UK
- Dr Christina Wojewoda, Pathologist, University of Vermont Medical Center, Associate Professor, Larner College of Medicine, UVM, Vermont, Burlington, USA
- Dr Elitza Theel, Director of the Infectious Diseases Serology Laboratory, Co-Director of the Vector-Borne Diseases Service Line, Mayo Clinic, Rochester, Minnesota, USA
- Dr Fouzia Jabeen, Consultant Microbiologist/Virologist, Sheikh Khalifa Medical City, Abu Dhabi, UAE
- Dr Giuseppe Togni, Microbiology Scientific Manager, Unilabs, Neuchâtel, Switzerland
- Dr Ranganathan N Iyer, Consultant Clinical Microbiology & Infection Control, Gleneagles Global Hospital & Rainbow Hospital for Children, Hyderabad, India
- Dr Yetti Hernaningsih, Lecturer, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
- Dr Zulfa Omar Al Deesi, Acting Head of Pathology Section, Head of Microbiology and Infection Control Unit – Pathology and Genetics Department, Latifa Hospital for Women and Children, Dubai, UAE
